Cannabis Breaks Through
Ever heard the expression “the greater the risk, the greater the reward?” Obviously, you did grow up here. It’s normally used to illustrate that an investment in which expectations are more difficult to determine, or are more likely to be unmet, should demand a higher upside given its uncertainty or reduced chances for success. This expression is much further reaching of course, extending to every facet of our lives.
This idea fully embraces the understanding that outlying events, more rare and volatile over the more frequent and average, are responsible for the most extreme changes to a particular environment.
So far in 2018 no other sector of the economy has proven as volatile and as rapid a producer of change as Cannabis. Hemp production looks like it might be accepted at the federal level, although with serious implications for those with past criminal convictions, with the 2018 Farm Bill while sentiment across the country is shifting if not towards total legalization, then towards a drastic demand for further research. A paradigm shift in consumer education and information availability has created a need for an overhaul of our understanding of Cannabis, including its entire historical, genetic, and medically applicable significance.
And, in addition to the publicly traded stocks churning out unprecedented returns of which I can’t wait to look into later, there are the advancements within the scientific community regarding Cannabis. Cannabis Now recently published an article in their August issue diving deep into the process and hopeful growth of a Colorado based company that’s exploring the established, and yet burgeoning, field of genomic editing.
Ebbu, located in Evergreen, is taking on the painstaking task of isolating cannabinoids to the ends of being able to harvest specific compounds from a plant, and more expeditiously than traditional cloning methods. They are mastering the process of tissue culturing in order to speed up the process of growing a stable base of single cannabinoid-producing plants. And with more control over the growth characteristics of the plant, as well as mitigation of pathogenic possibilities, consistent quality and deliverable characteristics can be achieved over a much shorter timeline.
Not only are we approaching advancements in our precise understanding of this plants’ properties, but the advent and impacts of hemp as an industrial commodity and a widespread educational transition all become warranted avenues in which to seek further insight. We’re in a position to discuss in detail, topics which dominate the prevailing conversations within every other agricultural, medical, and industrial sector. Except we’re even better poised to reinvent those conversations. As Canada approaches full legalization in October, let’s embrace an inevitably volatile start knowing it’s in this volatility that the greatest potential for true change can take place.